• Chadi A Hage, Eva M Carmona, Oleg Epelbaum, Scott E Evans, Luke M Gabe, Qusay Haydour, Kenneth S Knox, Jay K Kolls, M Hassan Murad, Nancy L Wengenack, and Andrew H Limper.
• Am. J. Respir. Crit. Care Med. 2019 Sep 1; 200 (5): 535550535-550.

AbstractBackground: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature related to diagnosis of invasive pulmonary aspergillosis, invasive candidiasis, and the common endemic mycoses was systematically reviewed. Meta-analysis was performed when appropriate. Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation approach.Results: This guideline includes specific recommendations on the use of galactomannan testing in serum and BAL and for the diagnosis of invasive pulmonary aspergillosis, the role of PCR in the diagnosis of invasive pulmonary aspergillosis, the role of β-d-glucan assays in the diagnosis of invasive candidiasis, and the application of serology and antigen testing in the diagnosis of the endemic mycoses.Conclusions: Rapid, accurate diagnosis of fungal infections relies on appropriate application of laboratory testing, including antigen testing, serological testing, and PCR-based assays.

31 keywords...

hide…